Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Long-Term Results of a Hybrid Revascularization Procedure for Peripheral Arterial Disease.

Okadome J, Matsumoto T, Aoyagi Y, Matsuda D, Tanaka S, Kawakubo E, Kyuragi R, Morisaki K, Homma K, Iwasa K, Ohmine T, Guntani A, Fukunaga R, Maehara Y.

Fukuoka Igaku Zasshi. 2015 Sep;106(9):254-61.

PMID:
26742218
2.
3.
4.

LeukoCatch, a quick and efficient tool for the preparation of leukocyte extracts from blood.

Okuzaki D, Kimura S, Yabuta N, Ohmine T, Nojima H.

BMC Clin Pathol. 2011 Aug 17;11:9. doi: 10.1186/1472-6890-11-9.

5.

The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.

Matsumoto T, Iwasa K, Kyuragi R, Honma K, Guntani A, Ohmine T, Itoh H, Onohara T, Maehara Y.

Int Angiol. 2010 Apr;29(2 Suppl):49-54.

PMID:
20357749
6.

Long-term Results of Reconstructive Surgery for the Unilateral Aortoiliac Occlusive Disease and Future Risks of Contralateral Iliac Events.

Onohara T, Takano T, Takai M, Hu H, Ohmine T, Fukunaga R, Furuyama T, Maehara Y.

Ann Vasc Dis. 2010;3(1):60-7. doi: 10.3400/avd.AVDoa09033. Epub 2010 Jul 21.

7.

The involvement of aldosterone in cyclic stretch-mediated activation of NADPH oxidase in vascular smooth muscle cells.

Ohmine T, Miwa Y, Takahashi-Yanaga F, Morimoto S, Maehara Y, Sasaguri T.

Hypertens Res. 2009 Aug;32(8):690-9. doi: 10.1038/hr.2009.76. Epub 2009 May 29.

PMID:
19478813
8.

Association between arterial stiffness and cerebral white matter lesions in community-dwelling elderly subjects.

Ohmine T, Miwa Y, Yao H, Yuzuriha T, Takashima Y, Uchino A, Takahashi-Yanaga F, Morimoto S, Maehara Y, Sasaguri T.

Hypertens Res. 2008 Jan;31(1):75-81. doi: 10.1291/hypres.31.75.

PMID:
18360021
9.

Urine flow cytometer quantification of leukocytes in samples containing a large proportion of lymphocytes.

Yamanishi H, Imai N, Ohmine T, Nishiyama M, Suehisa E, Kanakura Y, Iwatani Y.

Clin Biochem. 2006 Aug;39(8):857-9. Epub 2006 May 26.

PMID:
16828730
10.

Anti-HIV-1 activities and pharmacokinetics of new arylpiperazinyl fluoroquinolones.

Ohmine T, Katsube T, Tsuzaki Y, Kazui M, Kobayashi N, Komai T, Hagihara M, Nishigaki T, Iwamoto A, Kimura T, Kashiwase H, Yamashita M.

Bioorg Med Chem Lett. 2002 Mar 11;12(5):739-42.

PMID:
11858992
11.

Biologically active oligodeoxyribonucleotides. Part 12: N2-methylation of 2'-deoxyguanosines enhances stability of parallel G-quadruplex and anti-HIV-1 activity.

Koizumi M, Akahori K, Ohmine T, Tsutsumi S, Sone J, Kosaka T, Kaneko M, Kimura S, Shimada K.

Bioorg Med Chem Lett. 2000 Oct 2;10(19):2213-6.

PMID:
11012032
12.

Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: a new class of anti-HIV agents.

Hagihara M, Kashiwase H, Katsube T, Kimura T, Komai T, Momota K, Ohmine T, Nishigaki T, Kimura S, Shimada K.

Bioorg Med Chem Lett. 1999 Nov 1;9(21):3063-8.

PMID:
10560726
13.

Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activity.

Koizumi M, Koga R, Hotoda H, Ohmine T, Furukawa H, Agatsuma T, Nishigaki T, Abe K, Kosaka T, Tsutsumi S, Sone J, Kaneko M, Kimura S, Shimada K.

Bioorg Med Chem. 1998 Dec;6(12):2469-75.

PMID:
9925303
14.

A new fluoroquinolone derivative exhibits inhibitory activity against human immunodeficiency virus type 1 replication.

Kashiwase H, Momota K, Ohmine T, Komai T, Kimura T, Katsube T, Nishigaki T, Kimura S, Shimada K, Furukawa H.

Chemotherapy. 1999 Jan-Feb;45(1):48-55.

PMID:
9876209
15.

Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure.

Hotoda H, Koizumi M, Koga R, Kaneko M, Momota K, Ohmine T, Furukawa H, Agatsuma T, Nishigaki T, Sone J, Tsutsumi S, Kosaka T, Abe K, Kimura S, Shimada K.

J Med Chem. 1998 Sep 10;41(19):3655-63.

PMID:
9733490
16.

Biologically active oligodeoxyribonucleotides. 10: anti-HIV-1 activity and stability of modified hexanucleotides containing glycerol-skeleton.

Hotoda H, Koizumi M, Ohmine T, Furukawa H, Nishigaki T, Abe K, Kosaka T, Tsutsumi S, Sone J, Kaneko M.

Nucleosides Nucleotides. 1998 Jan-Mar;17(1-3):243-52.

PMID:
9708349
17.

Biologically active oligodeoxyribonucleotides--IX. Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3'- and 5'-end-modification.

Koizumi M, Koga R, Hotoda H, Momota K, Ohmine T, Furukawa H, Agatsuma T, Nishigaki T, Abe K, Kosaka T, Tsutsumi S, Sone J, Kaneko M, Kimura S, Shimada K.

Bioorg Med Chem. 1997 Dec;5(12):2235-43.

PMID:
9459021
18.

[Evaluation of gelatin particle agglutination method for detection of Treponema pallidum antibody].

Deguchi M, Hosotsubo H, Yamashita N, Ohmine T, Asari S.

Kansenshogaku Zasshi. 1994 Oct;68(10):1271-7. Japanese.

PMID:
7996026
19.

Genomic organization of the human homologue of the rat pancreatic elastase I gene.

Kawashima I, Tani T, Mita-Honjo K, Shimoda-Takano K, Ohmine T, Furukawa H, Takiguchi Y.

DNA Seq. 1992;2(5):303-12.

PMID:
1633328
20.

Characterization of a silent gene for human pancreatic elastase I: structure of the 5'-flanking region.

Tani T, Kawashima I, Furukawa H, Ohmine T, Takiguchi Y.

J Biochem. 1987 Mar;101(3):591-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk